We are live on
!
Find out more
ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
139 hedge funds and large institutions have $755M invested in Intra-Cellular Therapies Inc. in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 64 increasing their positions, 26 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
146% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 26
41% more call options, than puts
Call options by funds: $10.9M | Put options by funds: $7.69M
32% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 25
5% more funds holding
Funds holding: 133 → 139 (+6)
42% less capital invested
Capital invested by funds: $1.3B → $755M (-$546M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
139
Holders Change
+6
Holders Change %
+4.51%
% of All Funds
3.06%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
33
Increased
64
Reduced
26
Closed
25
Calls
$10.9M
Puts
$7.69M
Net Calls
+$3.19M
Net Calls Change
+$292M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$30.8M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$29.7M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$25M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$22.6M |
| 5 |
SC
Samlyn Capital
New York
|
+$19.3M |
Top Sellers
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$20.1M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$13.9M |
| 3 |
Morgan Stanley
New York
|
-$7.93M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7.85M |
| 5 |
CCM
Consonance Capital Management
New York
|
-$6.96M |
